Zobrazeno 1 - 7
of 7
pro vyhledávání: '"J M, FIORE"'
Autor:
Amy Chadburn, Ruben Niesvizky, J. M. Fiore, Ethel Cesarman, Daniel Muss, Morton Coleman, Lale Kostakoglu, Michael W. Schuster, Stewart Kroll, Shankar Vallabhajosula, George F. Tidmarsh, John P. Leonard, Richard R. Furman, Stanley J. Goldsmith
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(24)
Purpose To evaluate the safety and efficacy of a sequential chemotherapy plus radioimmunotherapy (RIT) regimen in previously untreated follicular non-Hodgkin's lymphoma. Patients and Methods Thirty-five patients received an abbreviated course (three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::705e087bb9e0dbf2bc293ece23389f14
https://pubmed.ncbi.nlm.nih.gov/16110029
https://pubmed.ncbi.nlm.nih.gov/16110029
Autor:
J. M. Fiore, Jamie C. Ketas, Amy Chadburn, William A. Wegener, Heather Horne, Morton Coleman, Ruben Niesvizky, Tsiporah B. Shore, John P. Leonard, Richard R. Furman, C. Ding, Jacqueline Kovacs, David M. Goldenberg, Ivan Horak, Michelle Ashe
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(22)
PurposeTo explore the safety and therapeutic activity of combination anti–B-cell monoclonal antibody therapy in non-Hodgkin's lymphoma (NHL).Patients and MethodsTwenty-three patients with recurrent B-cell lymphoma received anti-CD22 epratuzumab 360
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614d173a86d838727c644ec6f1185ce7
https://pubmed.ncbi.nlm.nih.gov/15955901
https://pubmed.ncbi.nlm.nih.gov/15955901
Autor:
John P. Leonard, Morton Coleman, Ruben Niesvizky, Richard R. Furman, J. M. Fiore, Lena Mathews, Jamie C. Ketas, Michelle Ashe
Publikováno v:
Blood. 104:4600-4600
Although considered an indolent disease, marginal zone lymphoma (MZL) often requires treatment. No standard therapy has been clearly established. Mitoxantrone has been effective in combination for indolent lymphomas, and is associated with considerab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0ebb9c76baa715aeb9d7a5ebc2e131a
https://doi.org/10.1182/blood.v104.11.4600.4600
https://doi.org/10.1182/blood.v104.11.4600.4600
Autor:
Morton Coleman, J. M. Fiore, C. P. Sison, Mark S. Lachs, Jamie C. Ketas, John P. Leonard, Richard R. Furman, Abby B. Siegel, L. M. Mathews, Michelle Ashe
Publikováno v:
Journal of Clinical Oncology. 22:8166-8166
8166 Background: Age over 60 and impaired “performance status” (PS) are adverse prognostic features in the International Prognostic Index (IPI) for lymphoma. However, patients over 60 comprise a he...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::294434cef08258d165553a9f7bbbf006
https://doi.org/10.1200/jco.2004.22.90140.8166
https://doi.org/10.1200/jco.2004.22.90140.8166
Autor:
Stanley J. Goldsmith, Amy Chadburn, John P. Leonard, Richard R. Furman, Morton Coleman, Stewart Kroll, J. M. Fiore, Lale Kostakoglu, Michael W. Schuster
Publikováno v:
Journal of Clinical Oncology. 22:6518-6518
6518 Background: The sequential combination of chemotherapy and radioimmunotherapy offers a novel strategy for the initial management of NHL. Tositumomab and iodine I 131 tositumomab (Bexxar) have been demonstrated to have substantial clinical activi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68ff25a9fe1cb71a3e7da336fc9cd001
https://doi.org/10.1200/jco.2004.22.90140.6518
https://doi.org/10.1200/jco.2004.22.90140.6518
Autor:
Richard R. Furman, J. M. Fiore, Morton Coleman, Daniel Muss, P. Stewart, Stewart Kroll, John P. Leonard, J. Mones, Lale Kostakoglu, Stanley J. Goldsmith
Publikováno v:
Journal of Clinical Oncology. 22:6575-6575
6575 Introduction: The Bexxar therapeutic regimen can produce durable and complete responses in patients with relapsed/refractory low-grade NHL. Virtually all previous studies of radioimmunotherape...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36243878dff8e360e7911cdf59f3008d
https://doi.org/10.1200/jco.2004.22.90140.6575
https://doi.org/10.1200/jco.2004.22.90140.6575
Publikováno v:
American review of tuberculosis. 74(2 Part 1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::603e8b8bf9627efea9a76bdae344af06
https://pubmed.ncbi.nlm.nih.gov/13340157
https://pubmed.ncbi.nlm.nih.gov/13340157